Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.7740
+0.0820 (11.85%)
At close: Jul 16, 2026, 4:00 PM EDT
0.7419
-0.0321 (-4.15%)
After-hours: Jul 16, 2026, 4:54 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $21.67 million as of July 16, 2026. Its market cap has decreased by -56.42% in one year.
Market Cap
21.67M
Enterprise Value
5.37M
1-Year Change
-56.42%
Ranking
Category
Stock Price
$0.77
ChartMarket Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $21.67M, a decrease of -82.35%. That is a compound annual growth rate of -23.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 21.67M | -57.69% |
| Dec 31, 2025 | 51.21M | -84.03% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 21.79M |
| NewcelX | 21.43M |
| Tevogen Bio Holdings | 21.02M |
| Cellectar Biosciences | 21.02M |
| CEL-SCI | 20.10M |
| Longeveron | 19.66M |
| Atossa Therapeutics | 19.46M |
| SeaStar Medical Holding | 19.30M |